Adverse effect of the CCR5 promoter -2459A allele on HIV-1 disease progression

Journal of Medical Virology

Volumn 65, Issue 3, 2001, Pages 441-444

  Knudsen, Troels B ^a   Kristiansen, Thomas B ^b   Katzenstein, Terese L ^a   Eugen Olsen, Jesper ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

59029 A G; AIDS; CCR5 receptor; Chemokine receptors; Human genetic polymorphism

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLELE; ARTICLE; DISEASE COURSE; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; VIRUS INFECTION;

ALLELES; COHORT STUDIES; DISEASE PROGRESSION; GENOTYPE; HIV INFECTIONS; HIV-1; HOMOZYGOTE; HUMANS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RECEPTORS, CCR5; RECEPTORS, CHEMOKINE;

EID: 0034800634     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.2054     Document Type: Article

References (18)

1. CCR5 promoter polymorphisms, CCR5 59029A and CCR5 59353C, are under represented in HIV-1-infected long-term non-progressors
2. Chemokine receptor polymorphisms and human immunodeficiency virus disease progression
3. Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals
4. Chemokine receptor CCR2b 64I polymorphism and its relation to CD4 counts and disease progression in HIV infected individuals
5. Dual effect of CCR5 delta 32 gene deletion in HIV-1-infected patients
6. Positive influence of the Delta32CCR5 allele on response to highly active antiretroviral therapy (HAART) in HIV-1 infected patients
7. Chemokine receptors and their crucial role in human immunodeficiency virus infection: Major breakthroughs in HIV research
8. Genetic acceleration of AIDS progression by a promoter variant of CCR5
9. CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS)
10. The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression
11. CCR5 Δ32 gene deletion in HIV-1 infected patients
12. Genealogy of the CCR5 locus and chemokine gene variants associated with a CCR5 promoter mutation
13. Evolution of human and non-human primate CC chemokine receptor 5 gene and mRNA. Potential roles for haplotype and mRNA diversity, differential haplotype-specific transcriptional activity, and altered transcription factor binding to polymorphic nucleotides in the pathogenesis of HIV-1 and simian immunodeficiency virus
14. Effect of chemokine receptor gene polymorphisms on the response to potent antiviral therapy
15. Influence of nucleotide polymorphisms in the CCR2 gene and the CCR5 promoter on the expression of cell surface CCR5 and CXCR4
16. CCR5 Δ32 gene deletion in HIV-1 infected patients
17. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression
18. The role of a stromal cell-derived-factor-1 chemokine gene variant in the clinical course of HIV-1 infection